Former Bristol Myers Squibb Global Medical Affairs Lead brings over 25 years of experience to Pliant SOUTH SAN FRANCISCO, ...

Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that on September 30, 2024 it granted stock options to purchase an ...

We look forward to presenting our latest intercom solutions at NAB NY 2024,” said Gary Rosen, Vice President of Global Sales ...

Pliant Technologies, a leading provider of professional wireless intercom solutions, has announced that it will be showing a ...

The National Democratic Congress (NDC) has criticised the Ghana Police Service for allowing itself to be controlled and used ...

On Tuesday, Pliant Therapeutics Inc (PLRX) stock saw a modest uptick, ending the day at $11.33 which represents a slight increase of $0.01 or 0.09% from the prior close of $11.32. The stock opened at ...

SOUTH SAN FRANCISCO, CA - Pliant Therapeutics, Inc. (NASDAQ:PLRX), a biopharmaceutical company, announced on Monday an update to its corporate bylaws to reflect recent changes in Delaware law.

Tim Walz versus J.D. Vance was the anti-Trump debate. There were no references to the animal kingdom in this ...

Leerink Partners has recently resumed Pliant Therapeutics Inc (PLRX) stock to Outperform rating, as announced on September 9, 2024, according to Finviz. Earlier, on December 8, 2023, Wells Fargo had ...

SOUTH SAN FRANCISCO, CA - Pliant Therapeutics, Inc. (NASDAQ:PLRX), a biopharmaceutical company, announced on Monday an update to its corporate bylaws to reflect recent changes in Delaware law. The ...